AntriaBio, Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (26)

Latest Posts

About This Stock More About This Stock
The Truth Behind The Story Of Inhale Insulin Exubera And Afrezza
Article By: Dr. Hung Tran
Tuesday, September 9, 2014 9:45 PM EDT
MannKind Corporation and Sanofi are poised to launch a new form of fast acting insulin called Afrezza. But will investors be able to forget their disappointment Nektar Therapeutics' insulin inhaler, Exubera, to recognize Afrezza's value?
In this article: PFE, SNY, MNKD, NKTR, ANTB
Read

PARTNER HEADLINES

Latest Tweets for $ANTB

No tweets yet!